Want to see IQV full AI Analyst Report?
Operating Profit by Segment
Shows profitability across various business segments, indicating which operations are most efficient and where there may be opportunities or challenges.R&D Solutions is the steady profit engine—consistent growth and recent uplift align with management’s double‑digit bookings and backlog conversion thesis—while Technology & Analytics is lumpier and less reliably accretive. The appearance of a material Commercial Solutions profit in the most recent quarter signals that organic acceleration and AI‑driven client wins are starting to translate to the P&L. Offsetting upside: heavy depreciation, rising restructuring charges and corporate costs are persistent margin drags, and elevated leverage means cash conversion and pass‑through normalization will determine sustainability.
Date | Technology and Analytics Solutions | Research and Development Solutions | Contract Sales and Medical Solutions | Corporate and Unallocated | Depreciation and Amortization | Restructuring Costs | Commercial Solutions |
|---|---|---|---|---|---|---|---|
Jun 30, 2026 | $0.00 | $526.00M | $0.00 | -$84.00M | -$292.00M | -$63.00M | $419.00M |
Mar 31, 2026 | $0.00 | $472.00M | $0.00 | $0.00 | -$288.00M | -$51.00M | $381.00M |
Dec 31, 2025 | $476.00M | $466.00M | $12.00M | $14.00M | -$317.00M | -$24.00M | $0.00 |
Sep 30, 2025 | $370.00M | $496.00M | $13.00M | -$20.00M | -$286.00M | -$20.00M | $0.00 |
Jun 30, 2025 | $389.00M | $451.00M | $12.00M | -$38.00M | -$276.00M | -$32.00M | $0.00 |
Mar 31, 2025 | $360.00M | $460.00M | $11.00M | -$41.00M | -$265.00M | -$29.00M | $0.00 |
Dec 31, 2024 | $421.00M | $478.00M | $13.00M | $13.00M | -$303.00M | $4.00M | $0.00 |
Sep 30, 2024 | $405.00M | $498.00M | $12.00M | -$59.00M | -$278.00M | -$28.00M | $0.00 |
Jun 30, 2024 | $361.00M | $493.00M | $9.00M | -$46.00M | -$269.00M | -$28.00M | $0.00 |
Mar 31, 2024 | $335.00M | $479.00M | $13.00M | -$42.00M | -$264.00M | -$15.00M | $0.00 |